Gene Therapy: The Woman Who Views Aging As A Disease

Elizabeth Parrish is the founder and CEO of BioViva, a biotech company which advocates gene and cell therapies to treat the diseases of aging. She is a major advocate of patient access to these revolutionary treatments, and became a test subject in September 2015 after receiving treatment for what she believes is the most common 'disease' - aging. To combat the process of aging, she subjected herself to two kinds of therapy - telomerase therapy and myostatin inhibitor.

University Herald


Avi Roy

- PhD student researching Aging, Mitochondria, and Regenerative Medicine - I currently write for The Conversation ( and I have written for The Guardian ( - Ringleader of the Oxford University Scientific Society - Co-conspirator at the Oxford Transhumanism and Emerging Technologies - Designing exciting events with the British Science Association Oxford - Advisory Board member at Lifeboat Foundation's Life Extension Board, and the Sustainability Board - Also, I am an Ultimate (frisbee) enthusiast - Yes, unfortunately that's me trying to catch the frisbee